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 Parkinson’s disease (PD) is a degenerative condition of the brain of uncertain cause that mainly affects 
older people. Shaking is a distinctive feature of the disease, but slowness, poverty of movement and stiffness 
interfere with everyday life. A large number of known pathogenic mutations of genes related to PD have been 
identified. The DJ-1 gene, one of PARK genes, is considered as the primary cause of PD in different 
populations. The analysis of mutation frequency of the DJ-1 gene in Vietnamese PD patients is necessary to 
clarify the pathogenic associations of PD with the DJ-1 gene and to understand the pathogenesis and genetic 
mechanisms of PD. In this study, genomic DNA was extracted from peripheral blood of 30 PD patients (mean 
age 64.11 ± 7.31 years) and 20 controls and directed Sanger sequencing of one fragment of DJ-1 gene, 
containing the introns 4 and 5 as well as exon 5. The obtained results showed that there were 13 heterozygous 
or homozygous point mutations in introns 4 and 5. The late-onset sporadic PD (LOPD) patient carried a single 
homozygous mutation in intron 5 (IVS5+31G>A), and others had a heterozygous mutation, all of unknown 
significance.  Moreover, both the Ala86Glu and Gly95Leu mutations in exon 5 were present in one LOPD 
patient suggesting possible change of functional protein. Analysis of these mutations were shown the 
nonsynonymous and uncertain significant mutation, therefore they may not be related to pathogenic mutations 
of PD. Further research is needed to study the contribution of the novel found mutation in other PARK genes to 
the pathogenesis of Vietnamese PD patients. 
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INTRODUCTION 
 At that moment, epidemiologic studies have 
highlighted the effects of interactions between genetic 
and environmental factors on the clinical signs of PD. 
An increasing number of genetic loci and numerous 
risk factors have been discovered, starting from the 
familiar genes responsible for the Mendelian inherited 
forms, such as the autosomal dominant genes (SNCA, 
LRRK2, VPS35, GBA), the typical recessive (PARK2, 
PINK1, PARK7), the atypical recessive ones 
(ATP13A2, PLA2G6, FBXO7) (Klein, Westenberger, 
2012) and other risk genes recently linked to the 
disease such as GBA (Sidransky et al., 2009) and 
GCH1 (Kefalopoulou et al., 2014).  
 PARK7 was the third gene identified in 2001 as 
responsible of PD. It encodes a conserved 
multifunctional protein belonging to the peptidase 
C56 family (also called DJ-1). The DJ-1 gene 
contains 8 exons distributed over 24 kb. It was 
originally identified and described as an oncogene 
and the 189 amino acid protein is highly conserved 
across species (Bonifati et al., 2003). DJ-1 appears 
to have several functions within the cell, in human 
and murine cell lines, DJ-1 has been identified as a 
hydroperoxide-responsive, which suggests a function 
as an antioxidant protein (Mitsumoto, Nakagawa, 
2001). Originally recognized as a c-myc interacting 
protein (Rakshit et al., 2014), DJ-1 has been 
identified as an infertility related protein (Honbou et 
al., 2003; Saito et al., 2014), associated with RNA 
stabilization (Malgieri, Eliezer, 2008; Matsuda et al., 
2017) and shown to convert to a more acidic form 
under conditions of oxidative stress (Bjorkblom et 
al., 2014; Mitsumoto, Nakagawa, 2001; Yanagida et 
al., 2009). Oxidative modifications of DJ-1 have 
been implicated in the mechanisms of neuronal death 
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and the pathogenesis of PD. It has been suggested 
that DJ-1 protect neurons against oxidative stress by 
acting as a redox-dependent chaperone. The protein 
is normally found in the cytoplasm and oxidative 
stress promotes relocation to mitochondria where it 
protects against mitochondrial toxins (Lin et al., 
2012; Zhang et al., 2005). Mutations in the DJ-1 
gene have recently been shown to cause autosomal 
recessive PD (Healy et al., 2004). Moreover, the loss 
of function of DJ-1 caused by mutations in DJ-1 
causes a form of familial PD (Chen et al., 2017). It 
was recently shown that the DJ-1 protein is degraded 
by the ubiquitin proteasome system and that this 
process is expedited for the PD (Bonifati et al., 
2003). However, the mechanism by which loss of 
DJ-1 causes Parkinsonism is unclear currently. 
MATERIALS AND METHODS 
Patient selection 
 Thirty PD patients were recruited from the 
Military Central Hospital (Table 1). Standard 
neurological clinical examination of all patients was 
performed before participation. The diagnosis of PD 
was based on published criteria (Clarke et al., 2016). 
This study was approved by the Medical Ethics 
Committee of Military Medical University and 
conformed to the ethical standards of the Helsinki 
Declaration. All PD patients and volunteers provided 
written informed consent.  
 
Table 1. General Characteristics of Vietnamese PD patients. 
General Characteristics PD patients (n = 30) 
Age at time of study median, 
year 
65.5 ± 7.3 
Age at male median, year 64.7 ± 7.07 
Age at female median, year 63.6 ± 7.55 
Male sex, n (frequency) 21/30 (70%) 
Female sex, n (frequency) 9/30 (30%) 
 
Total DNA extraction, PCR and sequencing 
 A blood sample was collected from a peripheral 
vein of each patient using venipuncture, and genomic 
DNA was extracted according to the kit protocol 
(GeneJET Genomic DNA purification, Thermo 
Science, USA). One coding exon of the DJ-1 gene was 
amplified by polymerase chain reaction (PCR) under 
the following conditions: denaturation at 94°C for 15 
minutes, followed by 35 cycles of denaturation at 94°C, 
annealing at 63°C and elongation at 72°C for 30 
seconds each, and a final elongation step of 7 minutes 
at 72°C. PCR was carried out in a final volume of 50 µl 
including 2.5 mM MgCl2, 0.2 mM deoxynucleotide 
triphosphate, 0.5 µM forward and reverse primer 
(forward: 5'-AAATAGGTCAGAGAGCTTGTGG-3' 
and reverse: 5'-TCAAACCATCGAATGAAAGG-3'), 
1 U Taq polymerase (Promega- M8305, USA), and 10 
ng of DNA. The quality of the PCR products was 
analyzed by 2% agarose gel electrophoresis with size of 
PCR product ca. 260 bp. 
 Purification of the amplified fragment was 
performed by using GeneJET PCR purification kit 
(Thermo Science, USA). For sequence analysis, 
bidirectional dideoxy chain terminator sequencing 
was carried out according to the manufacturers’ 
instructions (BigDye, Applied Biosystems, UK) and 
the products were electrophoresed on an ABI 3500 
Genetic Analyzer (Applied Biosystems, CA, USA).  
Statistical Analysis 
 A sequence of human DJ-1 gene 
(NC_000001.11) in NCBI GenBank was used as 
reference sequence. The exon and protein sequences 
of DJ-1 were vailable in Ensemble database 
(http://www.ensembl.org). These sequences used to 
identify the location of exon 5. DNA sequences of 
both PD patients and controls were translated using 
BioEdit Software to get protein sequences. A 
multiple sequenced alignment of genes and proteins 
was perform by using ClustalW tool of BioEdit 
software. Alignment result was analyzed to find 
down the nucleotide and amino acid substitution. 
RESULTS AND DISCUSSION 
 In this study, we identified 18 known variant 
mutations among 30 PD patients (60 %) (see Table 2). 
There was only one male PD patient carried 3 mutation 
positions, including exon 5 and introns 4 and 5. Parallel 
mutations in introns 4 and 5 were 6 cases (20 %), and 
another single mutation in the intron 4 (6 PD patients) or 
intron 5 (5 PD patients). A large number of known 
mutations related to PD have been identified. In 
particular, DJ-1 mutations appear to be considerably 
frequent in our population, suggesting a strong genetic 
and/ or environmental factors influence. Further research 
is needed to verify the contribution of the novel found 
mutation in the pathogenesis of Vietnamese PD. 
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Table 2. Patient information with PD for the DJ-1 mutation in exon 5 and intron 4, 5. 
No ID Name Sex Age at sampling Position of mutation 
1 6E5 Nguyen Trung K Male 67 Exon 5, Intron 4, Intron 5 
2 7E5 Nguyen Viet H Male 50 Intron 4, Intron 5 
3 8E5 Hoang Van P Male 60 Intron 4 
4 9E5 Nguyen Duy M Male 75 Intron 5 
5 10E5 Ho Minh A Male 60 Intron 5 
6 12E5 Hoang H Male 74 Intron 4, Intron 5 
7 14E5 Quan Van T Male 61 Intron 4 
8 16E5 Le Huu K Male 71 Intron 4 
9 17E5 Le Van H Male 69 Intron 4 
10 18E5 Nguyen Dang D Male 78 Intron 4 
11 19E5 Nguyen Van Q Male 57 Intron 4, Intron 5 
12 22E5 Trinh Huu L Male 57 Intron 4 
13 23E5 Nguyen Dac C Male 60 Intron 4, Intron 5 
14 25E5 Trieu Thi T Female 69 Intron 5 
15 27E5 Nguyen Minh N Female 74 Intron 5 
16 28E5 Nguyen Van T Male 69 Intron 4, Intron 5 
17 29E5 Nguyen Anh S Male 68 Intron 5 
18 30E5 Pham Hong N Male 67 Intron 4, Intron 5 
 























4 T T C     -49 IVS4-49T>C  Heterozygous 
1 A A C     -38 IVS4-38A>C  Heterozygous 
1 T T G     -24 IVS4-24T>G  Heterozygous 
1 G G T     -16 IVS4-16G>T  Heterozygous 
1 T T C     -15 IVS4-15T>C  Heterozygous 
1 T T C     -14 IVS4-14T>C  Heterozygous 
2 T T C     -13 IVS4-13T>C  Heterozygous 
3 T T C     -12 IVS4-12T>C  Heterozygous 
1 A A G     -5 IVS4-5A>G  Heterozygous 
1 C C G     -4 IVS4-4C>G  Heterozygous 
7 G A A     31 IVS5+31G>A  Homozygous 
1 A A T     34 IVS5+34A>T  Heterozygous 
7 G G T     42 IVS5+42G>T  Heterozygous 
1 C C G A G 257 86  c.257C>G; p.A86G Ala>Glu Heterozygous 
1 
A A T Q L 284 95  
c.284A>T; 
p.G95L Gly>Leu Heterozygous 
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 We sequenced exon 5 and intron 4 and 5 of DJ-1 
in 30 PD patients with onset range of over 50 years 
old in an attempt to identify mutations causing 
disease and gain further insight into the role of DJ-1 
in PD, see table 3. 
 Here, we have searched for mutation in the 
intron border of exon 5 (see Table 3 and Figure 1). 
We detected a 13 mutation points in intron 4 and 5. 
In which, 10 heterozygous mutations in intron 4 
(e.g., IVS4-49T>C in 4 PD patients, IVS4-38A>C in 
1 PD patient, IVS4-24T>G in 1 PD patient, IVS4-
16G>T in 1 PD patient, IVS4-15T>C in 1 PD 
patient, IVS4-14T>C in 1 PD patient, IVS4-13T>C 
in 2 PD patients, IVS4-12T>C in 3 PD patients, 
IVS4-5A>G in 1 PD patient, and IVS4-4C>G in 1 
PD patient); 2 heterozygous mutations (e.g.,  
IVS5+34A>T in 1 PD patient and IVS5+42G>T in 7 
PD patients) and 1 homozygous mutation (e.g., 
IVS5+31G>A in 7 PD patients) in intron 5, but no 
mutation carries were identified among 20 controls. 
There are a few possible outcomes of these 
mutations; it could influence the effectiveness of 
intron splicing, it could lead to the accumulation of 
unspliced pre-RNA in the nucleus and be subject to 
rapid degradation, or it may result in the activation 
of an alternative cryptic splice site affecting the 
coding region of the gene. In all cases, this variant is 
predicted to have drastic consequences on DJ-1 gene 






































Figure 1. Sequence images of 13 point mutations in intron 4 and 5 in DJ-1 gene. A) 10 heterozygous mutations in intron 4; 
B) 2 heterozygous mutations and 1 homozygous mutation in intron 5. 
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 The two heterozygous mutations that alter amino 
acid (Ala86Glu and Gly95Leu) found in one 
individual comparing with the wild type sequence 
(see Table 3 and Figure 2). Although, no other 
sequence alterations or deletion or duplication were 
detected, these mutations predicted to result in a loss 
of functional protein. Recently, mutations in DJ-1 
were identified in consanguineous Dutch and Italian 
kindreds. In the Dutch kindred, a 14 kb genomic 
deletion removed the promoter region and the first 
five exons (D125). In the Italian kindred, a highly 
conserved amino acid (leucine) was altered to proline 
(L166P). Both mutations showed complete 
segregation with disease in homozygous or 
heterozygous individuals, suggesting that loss of 
function of DJ-1 is pathogenic (Bonifati et al., 2003). 
In addition, the Ala167Ala mutation was previously 
identified in a PD patient (homozygote carrier) from 
the United Kingdom and in a patient from a North 
American material with Caucasian/Hispanic origin 
(heterozygote carrier) (Abou-Sleiman et al., 2006). 
This is the first report on DJ-1 mutation identified in 
Vietnamese PD patients. This is the first report on 
DJ-1 mutation identified in Vietnamese PD patients. 
Therefore, there are several possibilities concerning 
to the mechanism of these alter mutations. Several 
possibilities have been suggested for mutations 
including alterations of mRNA stability, secondary 
structure, transcriptional activity, or changes in 
protein synthesis, folding, levels, turnover and/or 
function. Moreover, the unidentified genetic 
pathways and differences in environmental factors 
might contribute to the phenotypic variability among 
PD patients. We report here all the changes found in 
this series of PD cases and controls. The pathogenic 
role of these mutations will become clearer as other 
























 In conclusion, we identified the presence of 18 
mutations in the exon 5 and introns 4 and 5 of DJ-1 
gene. Although our hypothesis that these mutations 
would contribute to disease, the nonsynonymous and 
uncertain significance of two variant mutations 
(c.257C>G; p.A86G and c.284A>T; p.G95L) in DJ-
1 gene was no parameter for defining fast-evolving 
and slow-evolving protein-coding genes regarding 
pathogenicity. To clarify the pathogenic associations 
of DJ-1 gene with PD, further studies focusing on 
large genetic cohort and epigenetic inactivation 
mechanisms involving these genes are required in 
PD patients and in their relatives with suspected 
symptoms.  
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PHÂN TÍCH ĐỘT BIẾN CỦA GEN DJ-1 Ở BỆNH NHÂN PARKINSON VIỆT NAM 
 
Hồ Trường Giang1, Nguyễn Đức Hiếu2, Nguyễn Thị Hoài Thu2, Vũ Xuân Nghĩa3, Võ Thị Bích Thủy2 
1Học viện Quân y, Bộ Quốc phòng 
2Viện Nghiên cứu hệ Gen, Viện Hàn lâm Khoa học và Công nghệ Việt Nam  
TÓM TẮT 
 Bệnh Parkinson (PD) là một tình trạng thoái hóa của thần kinh trung ương với các nguyên nhân chưa được 
xác định chắc chắn nhưng chủ yếu tác động đến người già. Rối loạn vận động là đặc trưng của bệnh, cứng cơ, 
run, chuyển động chậm chạp làm ảnh hưởng đến cuộc sống hàng ngày của người bệnh.  Một số lượng lớn các 
đột biến trên các gen có liên quan đến bệnh Parkinson (PD) đã được tìm thấy. Gen DJ-1, là một gen thuộc 
nhóm gen PARK, được xác định là liên quan đến bệnh PD. Việc phân tích tần suất đột biến của gen DJ-1 ở 
bệnh nhân PD Việt Nam là cần thiết để làm rõ các mối liên hệ gây bệnh của gen DJ-1 với bệnh Parkinson và 
tìm hiểu về cơ chế gây bệnh và cơ chế di truyền của PD. Trong nghiên cứu này, mẫu DNA tổng số được tách 
chiết từ máu ngoại vi của 30 bệnh nhân PD (ở độ tuổi 64.11 ± 7.31), 20 mẫu đối chứng, và giải trình tự bằng 
Sanger một vùng mã hoá của DJ-1 (chứa intron 4 và 5, và exon 5). Kết quả chúng tôi đã sàng lọc được 13 điểm 
đột biến dị hợp tử hoặc đồng hợp tử xuất hiện trong intron 4 và 5. Có một bệnh nhân khởi phát bệnh muộn 
(LOPD) mang đột biến đồng hợp tử duy nhất ở intron 5 (IVS5+31G>A), các bệnh nhân còn lại đều mang đột 
biến dị hợp tử, nhưng tất cả các đột biến đều không có ý nghĩa.  Điều đáng chú ý là cả hai đột biến Ala86Glu 
và Gly95Leu trên exon 5 đều xuất hiện ở một bệnh nhân PD và điều này có thể dẫn đến một sự thay đổi của 
protein chức năng. Phân tích bằng tin sinh học hai đột biến trên cho thấy chúng đều là đột biến không đồng 
nhất và không chắc chắn, do vậy có thể chúng không có liên quan đến đột biến gây bệnh Parkinson. Trong 
tương lai, cần nghiên cứu thêm về vai trò của các đột biến mới ở các gen PARK khác có liên quan đến sinh 
bệnh học của các bệnh nhân mắc PD ở Việt Nam.  
Từ khóa: Bệnh Parkinson, exon 5, gen DJ-1, PARK loci, giải trình tự gen 
 
 
